EUVIMEDOpdag EUVIMED
Crossref

Real world evidence of clinical predictors of glycaemic response to glucose‐lowering drugs among Chinese with type 2 diabetes

Hongjiang Wu, Eric S H Lau, Aimin Yang, Baoqi Fan iD, Ronald C W Ma iD, Alice P S Kong, Elaine Chow, Wing-Yee So, Juliana C N Chan iD, Andrea O Y Luk iD

Diabetes/Metabolism Research and Reviews · 2023-05 · 39 (4)

DOI: 10.1002/dmrr.3615 ↗

At a glance

Journal article in Diabetes/Metabolism Research and Reviews, published online on 2023-02-02. Written by Hongjiang Wu and 9 co-authors. Institution: Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China. Major MEDLINE topics: Diabetes Mellitus, Type 2, Metformin, Dipeptidyl-Peptidase IV Inhibitors. Cited 6 times so far (Crossref); 39 references. Funded by: Research Grants Council, University Grants Committee.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

To examine whether simple clinical features can predict the 1‐year glycaemic response to glucose‐lowering drugs (GLDs) among Chinese with type 2 diabetes. Materials and Methods We used data from a diabetes risk assessment and complication screening programme and electronic medical records. We used linear regression models to examine the association between clinical features and 1‐year glycaemic response to GLDs.

Results

Use of metformin ( n = 15,433), sulphonylureas (SU) ( n = 15,190), dipeptidyl peptidase‐4 inhibitor (DPP‐4i) ( n = 7947), thiazolidinedione (TZD) ( n = 4107), and sodium‐glucose cotransporter 2 inhibitors (SGLT‐2i) ( n = 1883) were associated with a mean reduction of HbA1c ranging from 0.7% to 1.3% at one year. Men had a greater response to SU but a poorer response to metformin and TZD. Older age predicted a better response to all GLDs but not SGLT‐2i, whereas increasing diabetes duration was associated with a poorer response to all GLDs except for DPP‐4i. Obese patients responded greater to TZD and SGLT‐2i but poorer to SU than those with normal weight. Patients with a higher level of triglycerides to high‐density lipoprotein cholesterol ratio had a greater glycaemic response to TZD but a smaller response to SU and DPP‐4i.

Conclusions

Glycaemic response to GLDs differed considerably by clinical features among Chinese patients with type 2 diabetes.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2MetforminDipeptidyl-Peptidase IV InhibitorsMaleHumansGlucoseEast Asian PeopleHypoglycemic AgentsSulfonylurea CompoundsThiazolidinediones

Author keywords

Chineseglucose lowering drugsglycaemic responsepredictorstype 2 diabetes

Substances

GlucoseHypoglycemic AgentsMetforminSulfonylurea CompoundsDipeptidyl-Peptidase IV Inhibitors2,4-thiazolidinedioneThiazolidinediones

Authors and institutions

  • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.
  • Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
  • Hong Kong Hospital Authority, Hong Kong, China.

ORCID profiles: Baoqi Fan, Ronald C W Ma, Juliana C N Chan, Andrea O Y Luk

Funding

  • Research Grants Council, University Grants Committee

Cite

APA

Wu, H., Lau, E. S. H., Yang, A., Fan, B., Ma, R. C. W., Kong, A. P. S., Chow, E., So, W. Y., Chan, J. C. N., & Luk, A. O. Y. (2023). Real world evidence of clinical predictors of glycaemic response to glucose‐lowering drugs among Chinese with type 2 diabetes. Diabetes/Metabolism Research and Reviews, 39(4). https://doi.org/10.1002/dmrr.3615

Vancouver

Wu H, Lau ESH, Yang A, Fan B, Ma RCW, Kong APS, et al. Real world evidence of clinical predictors of glycaemic response to glucose‐lowering drugs among Chinese with type 2 diabetes. Diabetes/Metabolism Research and Reviews. 2023;39(4). doi:10.1002/dmrr.3615

BibTeX
@article{Wu2023,
  author = {Wu, Hongjiang and Lau, Eric S H and Yang, Aimin and Fan, Baoqi and Ma, Ronald C W and Kong, Alice P S and Chow, Elaine and So, Wing-Yee and Chan, Juliana C N and Luk, Andrea O Y},
  title = {Real world evidence of clinical predictors of glycaemic response to glucose‐lowering drugs among Chinese with type 2 diabetes},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2023},
  volume = {39},
  number = {4},
  doi = {10.1002/dmrr.3615}
}
Start for free →